Agenda

Ain Shams University Clinical Oncology Conference Agenda

TIME

27 November

27 November

28 November

28 November

HALL A

HALL B

HALL A

HALL B

9:00-9:30

Registration

9:30-10:00

Opening Ceremony

10:00-10:30

Management of HCC in Late Child A / early CHILD B: Benefit, toxicities

10:30-11:00

Chemotherapy in Hepatitis patients: the challenges

11:00-11:30

Hepatic surgery in HCC: Resection and liver transplantation timing

11:30-12:00 12:00-12:30 12:30-1:00

1:00-1:30

Break

Break

New therapeutics in advanced stage gastric carcinomas Management of gastric lymphoma Management of Imatinib resistant GIST: Therapeutics and surgical options

Therapeutic options in metastatic renal cell carcinoma Neo-adjuvant therapy for RCC: is there a role? Pancreatico-biliary surgery

1:30 – 2:00 SYMPOSIUM 2:00 – 2:30

Egyptian statistics and situation Risk factors and Screening of mesothelioma in Egypt

Management of muscle invasive bladder cancer

Evolving role of systemic therapy in mesothelioma Surgery for mesothelioma: Timing and new modalities

Should we treat SCC and adenocarcinoma of the bladder differently? The role of targeted therapy and PRRT in pancreatic NET

Prayer time And Break

New trends in castration resistant prostate cancer Hypo-fractionation in localized prostate cancer: toxicity and efficacy Intermittent ADT in Metastatic prostate cancer

Surgical milestones in limited stage SCLC Immunotherapy in NSCLC Optimizing treatment in lung neuro-endocrinal tumors

2:30-3:00 LUNCH

SYMPOSIUM(2.5-3.5)

3:00-3:30

3:30-4:00

Molecular pathogenesis of Colorectal cancer

Novel modalities in NSCLC radiotherapy (IMRT, 3DCRT, Stereotaxy)

4:00-4:30

Fertility issues in rectal cancer patients.

Molecular analysis in management of NSCLC: when and for whom?

4:30-5:00

Adjuvant systemic therapy in colorectal cancer patients with MMR defects

Maintenance systemic therapy in NSCLC: is it debatable?

5:00-5:30

Controversies in hepatic resection for colorectal metastasis

Surgery for mediastinal Lymph node positive NSCLC

5:30-6:30

Break

6:30 – 7:30

Symposium

LUNCH(3.5-4.5) Adjuvant therapy after neoadjuvant treatment and resection of rectal cancers Multi-institutional experience for borderline resectable hepatic metastasis from colorectal cancer What's beyond 1st line in metastatic CRC

Screening of prostate cancer: is it worth debating in North African patients Prostate cancer radiotherapy: dose escalation; how and why? Management of ADT adverse events (andropause)

BREAK HEALTH ECONOMIC RESULTS

7:30-9:00

REWARDS ----- Closing ceremony

9:00 – 10:00

Gala Dinner

HALL C (BY RESERVATION) THURSDAY: HEALTH ECONOMICS EXPERT FORUM 1- Guidelines development for management of cancer patients in developing countries 2- National policies for adoption of novel therapeutics in Egyptian Oncology practice 3- Cost of palliative care: alternative options 4- Opportunities for cost-effectiveness research FRIDAY: ADVANCED RADIATION WORKSHOP 1. 2. 3. 4. 5. 6. 7.

New modalities in radiation oncology Imaging techniques in radiotherapy Controversies in contouring guidelines Tolerance doses in non-conventional radiotherapy techniques Quality assurance in radiotherapy Medical Physics and its contribution to radiotherapy research Updates in radiotherapy trials